Showing results (431-440 of 672) with videos related to
Sort By:
Pageof 68
Chemistry and Physics of Lipids|February 5, 1998
Dramatic increase of alpha-hydroxyaldehydes derived from plasmalogens in the aged human brainM Weisser, M Vieth, M Stolte, et al.Nature Biotechnology|October 3, 1999
Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT libraryG Münch, D Schicktanz, A Behme, et al.Journal of Neural Transmission. General Section|January 1, 1993
Isolation of a cDNA encoding the human brain serotonin transporterK P Lesch, B L Wolozin, H C Estler, et al.Annals of Neurology|August 12, 1999
Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystoniaG Becker, D Berg, W D Rausch, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 3, 2004
Impairment of G(salpha) function in human brain cortex of Alzheimer's disease: comparison with normal agingE Hashimoto, H Ozawa, T Saito, et al.Journal of Neural Transmission. Supplementum|January 1, 1994
Neuroprotection by dopamine agonistsK W Lange, W D Rausch, W Gsell, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylationG Münch, Y Taneli, E Schraven, et al.Journal of Neurology|February 24, 2001
Workshop II: "neuroprotection"--the Lugano consensusP Riederer, T Brücke, C Buhmann, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
Brofaromine (CGP 11 305 A): estimation of plasma concentrations by a biologic technique as compared to liquid chromatographyJ Fritze, T Becker, V Ziegler, et al.Neurochemistry International|May 28, 2010
Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of rhesus monkeyP Janssens de Varebeke, E Schallauer, W D Rausch, et al.Pageof 68